• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顽固性高血压治疗的生理适应性调整

Physiologic tailoring of treatment in resistant hypertension.

作者信息

Spence J David

机构信息

Stroke Prevention & Atherosclerosis Research Centre, 1400 Western Road, London, Ontario, Canada N6G 2V2.

出版信息

Curr Cardiol Rev. 2010 May;6(2):119-23. doi: 10.2174/157340310791162695.

DOI:10.2174/157340310791162695
PMID:21532778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2892077/
Abstract

Resistant hypertension is a major opportunity for prevention of cardiovascular disease. Despite widespread dissemination of consensus guidelines, most patients are uncontrolled with approaches that assume that all patients are the same. Causes of resistant hypertension include 1) non-compliance 2) consumption of substances that aggravate hypertension (such as salt, alcohol, nonsteroidal anti-inflammatory drugs, licorice, decongestants) and 3) secondary hypertension. Selecting the appropriate therapy for a patient depends on finding the cause of the hypertension. Once rare causes have been eliminated (such as pheochromocytoma, licorice, adult coarctation of the aorta), the cause will usually be found by intelligent interpretation (in the light of medications then being taken) of plasma renin and aldosterone.If stimulated renin is low and the aldosterone is high, the problem is primary aldosteronism, and the best treatment is usually aldosterone antagonists (spironolactone or eplerenone; high-dose amiloride for men where eplerenone is not available). If the renin is high, with secondary hyperaldosteronism, the best treatment is angiotensin receptor blockers or aliskiren. If the renin and aldosterone are both low the problem is over-activity of renal sodium channels and the treatment is amiloride. This approach is particularly important in patients of African origin, who are more likely to have low-renin hypertension.

摘要

顽固性高血压是预防心血管疾病的一个主要契机。尽管共识指南已广泛传播,但大多数患者采用的是假定所有患者情况相同的治疗方法,血压仍未得到控制。顽固性高血压的病因包括:1)治疗依从性差;2)摄入加重高血压的物质(如盐、酒精、非甾体抗炎药、甘草、减充血剂);3)继发性高血压。为患者选择合适的治疗方法取决于找出高血压的病因。一旦排除罕见病因(如嗜铬细胞瘤、甘草、成人主动脉缩窄),通常通过对血浆肾素和醛固酮进行合理分析(结合当时正在服用的药物)来找出病因。如果刺激肾素水平低而醛固酮水平高,问题就是原发性醛固酮增多症,最佳治疗方法通常是使用醛固酮拮抗剂(螺内酯或依普利酮;在无法获得依普利酮的情况下,男性可使用高剂量氨氯吡咪)。如果肾素水平高,伴有继发性醛固酮增多症,最佳治疗方法是使用血管紧张素受体阻滞剂或阿利吉仑。如果肾素和醛固酮水平都低,问题就是肾钠通道活性过高,治疗方法是使用氨氯吡咪。这种方法在非洲裔患者中尤为重要,因为他们更易患低肾素性高血压。

相似文献

1
Physiologic tailoring of treatment in resistant hypertension.顽固性高血压治疗的生理适应性调整
Curr Cardiol Rev. 2010 May;6(2):119-23. doi: 10.2174/157340310791162695.
2
Controlling resistant hypertension.控制耐药性高血压。
Stroke Vasc Neurol. 2018 Feb 24;3(2):69-75. doi: 10.1136/svn-2017-000138. eCollection 2018 Jun.
3
The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.螺内酯、氨氯吡咪、氯沙坦与噻嗪类药物(SALT)对低肾素性高血压和醛固酮-肾素比值升高患者的双盲交叉试验。
Circulation. 2007 Jul 17;116(3):268-75. doi: 10.1161/CIRCULATIONAHA.107.690396. Epub 2007 Jul 2.
4
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.耐药性高血压的内分泌和血液动力学变化,以及螺内酯或阿米洛利对血压的反应:PATHWAY-2 机制子研究。
Lancet Diabetes Endocrinol. 2018 Jun;6(6):464-475. doi: 10.1016/S2213-8587(18)30071-8. Epub 2018 Apr 11.
5
Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.抗高血压药物对原发性高血压和原发性醛固酮增多症鉴别诊断中醛固酮和肾素浓度的影响。
Clin Endocrinol (Oxf). 2002 Oct;57(4):457-65. doi: 10.1046/j.1365-2265.2002.01613.x.
6
Resistant hypertension and aldosteronism.顽固性高血压与醛固酮增多症。
Curr Hypertens Rep. 2007 Nov;9(5):353-9. doi: 10.1007/s11906-007-0066-7.
7
Normokalemic hyperaldosteronism in patients with resistant hypertension.顽固性高血压患者的正常血钾性醛固酮增多症
Isr Med Assoc J. 2002 Jan;4(1):17-20.
8
Aldosterone antagonism: an emerging strategy for effective blood pressure lowering.醛固酮拮抗作用:一种新兴的有效降压策略。
Curr Hypertens Rep. 2005 Jun;7(3):186-92. doi: 10.1007/s11906-005-0008-1.
9
A Patient with Bilateral Primary Aldosteronism Refractory to Oral Eplerenone Who Responded to Esaxerenone with Increased Renin Activity.一名双侧原发性醛固酮增多症患者,口服依普利酮无效,而使用依沙贝隆后肾素活性增加。
Am J Case Rep. 2020 Jan 7;21:e920615. doi: 10.12659/AJCR.920615.
10
Hypertension: renin-angiotensin-aldosterone system alterations.高血压:肾素-血管紧张素-醛固酮系统改变。
Circ Res. 2015 Mar 13;116(6):960-75. doi: 10.1161/CIRCRESAHA.116.303587.

引用本文的文献

1
Triple Antihypertensive Medication Prediction Score After Intracerebral Hemorrhage (the TRICH Score).脑出血后三联抗高血压药物预测评分(TRICH评分)。
Neurology. 2025 May 13;104(9):e213560. doi: 10.1212/WNL.0000000000213560. Epub 2025 Apr 4.
2
Licorice Root Associated With Intracranial Hemorrhagic Stroke and Cerebral Microbleeds.甘草根与颅内出血性中风和脑微出血有关。
Neurohospitalist. 2019 Jul;9(3):169-171. doi: 10.1177/1941874418805332. Epub 2018 Oct 15.
3
Genetics of resistant hypertension: a novel pharmacogenomics phenotype.

本文引用的文献

1
Update in primary aldosteronism.原发性醛固酮增多症的最新进展。
J Clin Endocrinol Metab. 2009 Oct;94(10):3623-30. doi: 10.1210/jc.2009-1399. Epub 2009 Sep 8.
2
Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis.环氧化酶抑制性一氧化氮供体萘普生辛酯与萘普生对骨关节炎患者全身血压的影响。
Am J Cardiol. 2009 Sep 15;104(6):840-5. doi: 10.1016/j.amjcard.2009.05.014.
3
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial.
难治性高血压的遗传学:一种新型药物基因组学表型。
Curr Hypertens Rep. 2015 Sep;17(9):583. doi: 10.1007/s11906-015-0583-8.
4
Intensive risk factor control in stroke prevention.卒中预防中的强化危险因素控制。
F1000Prime Rep. 2013 Oct 1;5:42. doi: 10.12703/P5-42.
5
Secondary stroke prevention.二级卒中预防。
Nat Rev Neurol. 2010 Sep;6(9):477-86. doi: 10.1038/nrneurol.2010.114. Epub 2010 Aug 10.
用于治疗但未控制的高血压患者校正的血浆肾素检测指导药物治疗算法:一项随机对照试验。
Am J Hypertens. 2009 Jul;22(7):792-801. doi: 10.1038/ajh.2009.63. Epub 2009 Apr 16.
4
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.《2009年心脏病和中风统计数据更新:美国心脏协会统计委员会及中风统计小组委员会报告》
Circulation. 2009 Jan 27;119(3):480-6. doi: 10.1161/CIRCULATIONAHA.108.191259.
5
Diagnosis of primary aldosteronism: for medical management, not just surgery.
J Hypertens. 2009 Jan;27(1):204-5; author reply 205. doi: 10.1097/HJH.0b013e32831b7687.
6
Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families.意大利以及澳大利亚和南美家族中,7号染色体p22区域存在II型家族性醛固酮增多症连锁关系的进一步证据。
J Hypertens. 2008 Aug;26(8):1577-82. doi: 10.1097/HJH.0b013e3283028352.
7
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.顽固性高血压:诊断、评估与治疗:美国心脏协会高血压研究理事会专业教育委员会的科学声明
Circulation. 2008 Jun 24;117(25):e510-26. doi: 10.1161/CIRCULATIONAHA.108.189141.
8
Aldosterone and vascular inflammation.醛固酮与血管炎症
Hypertension. 2008 Feb;51(2):161-7. doi: 10.1161/HYPERTENSIONAHA.107.095489. Epub 2008 Jan 2.
9
Differences in hypertension between blacks and whites: an overview.黑人和白人在高血压方面的差异:综述。
Cardiovasc J Afr. 2007 Jul-Aug;18(4):241-7.
10
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.原发性醛固酮增多症中的肾囊肿与低钾血症:治疗后的长期随访结果
J Hypertens. 2007 Jul;25(7):1443-50. doi: 10.1097/HJH.0b013e328126855b.